EXACTUS, INC. (OTCMKTS:EXDI) Files An 8-K Regulation FD Disclosure

EXACTUS, INC. (OTCMKTS:EXDI) Files An 8-K Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure

Exactus, Inc. (the Company) intends to participate in upcoming investor events. Any material or webcasts for these events will be posted to the Company\’s website at www.exactusinc.com. Senior management ofthe Company will be presenting the Company in private meetings scheduled to commence May 1, 2019 and will participate at the 9th Annual LD Micro Invitational Conference in Bel Air, California June 4-5, 2019.
On April 29, 2019 the Company issued a press release included as Exhibit 99.1 hereto. As discussed in the press release, the Company received an independent fairness opinion from Scalar, LLC in connection with the acquisition of two operating hemp farms located in Southwest Oregon consisting of approximately 200 acres that concluded that the acquisition of a 50.1% interest in and investment by the Company in its subsidiary, Exactus One World, LLC, is fair to the Company from a financial point of view.
On April 30, 2019 we issued an updated corporate presentation which the Company intends to utilize in connection with meetings and investor conferences. The updated corporate presentation has been included as Exhibit 99.2 hereto.
All statements at the conferences and in the corporate presentations, other than historical financial and other information, may be deemed to be forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in the forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
In accordance with General Instruction B.2. of Form 8-K, this information and the exhibits hereto shall not be deemed \”filed\” for purposes of Section 18 of the Securities Exchange Act of 1934 nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits
Exactus, Inc. Exhibit
EX-99.1 2 ex99-1.htm PRESS RELEASE Blueprint   Exhibit 99.1     Exactus Initiates Operations on Two 100-Acre SW Oregon Industrial Hemp Farms – Receives Positive Results from an Independent Fairness Opinion Conducted for Exactus’ Acquisition of 50.1% of Exactus One World,…
To view the full exhibit click here

Story continues below


Exactus, Inc. (Exactus), formerly Spiral Energy Tech, Inc., is a life science company. The Company will develop and commercialize Point-of-Care (POC) diagnostics for measuring proteolytic enzymes in the blood based on a detection platform. The Company’s primary business focus will be the development and commercialization of the FibriLyzer and related technology licensed by Exactus. The Company’s products will employ a disposable test biosensor strip combined with a portable hand held detection unit that provides a result in approximately 30 seconds. The Company intends to file to gain regulatory approval and launch its products in the United States and Europe.

An ad to help with our costs